teaser tg-mva

TG-MVA Development of an MVA-based prophylactic vaccine candidate against mpox.

Download the fact sheet

Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line-Derived MVA Vaccine Cadidate (TG-MVA) at WCID 2026.

Download the press release

N. Silvestre, et al.
World Congress on Infectious Diseases WCID 2026 – Abstract available on the WCID website – Download the abstract – Download the oral presentation